Applying Liquid Biopsies to Cancer Biomarkers in Circulating Tumors

The liquid biopsy has rapidly emerged as a method to minimize the amount of tissue needed for testing, making it a less invasive and safer alternative to more traditional procedures. As it continues to evolve, liquid biopsies offer exciting new options in the practice of pathology. In this episode, Maria Arcila, MD, FCAP, and JinJuan Yao, MD, FCAP, discuss the development of this new diagnostic tool. CAP Precision Medicine Resource Center: https://www.cap.org/member-resources/precision-medicine CAP and AMP recommendations on validation of cell-free DNA assays: https://www.jmdjournal.org/article/S1525-1578%2823%2900219-2/fulltext